FDA Looks To Capitol Hill For New Authority For Globalization Plan
This article was originally published in PharmAsia News
Executive Summary
Legislative fixes are required for U.S. FDA to implement its long-term strategy to use a coalition of regulators to secure the world drug supply chain, but the agency says it will not let that stop it from implementing its Pathway to Global Product Safety and Quality plan